What is behind the AI answer?

As SPMC adopts UpToDate® Expert AI, a bigger question emerges: what should clinicians expect from AI when the evidence behind the answer matters?

Southern Philippines Medical Center (SPMC) will make UpToDate® Expert AI available to its healthcare professionals in Davao, becoming the first government hospital in Southern Philippines to adopt the solution.

The development comes as generative AI makes health information increasingly accessible. But for healthcare professionals, access is only part of the story.

When an AI-generated answer sounds authoritative, what is it actually based on, and can the clinician examine the evidence behind it?

Why this story, why now?

Generative AI can deliver sophisticated answers in seconds. In healthcare, however, a convincing answer is not necessarily enough.

Clinicians need to know where medical information comes from, what evidence supports it, and whether they can examine that evidence themselves.

That question is becoming more relevant as healthcare professionals navigate growing volumes of medical information alongside digital sources that can range from high-quality clinical evidence to outdated, misleading or difficult-to-verify health information.

It also points to a distinction worth exploring: what changes when AI is developed specifically around clinical evidence rather than used as a general-purpose information tool?

What is different about UpToDate Expert AI?

UpToDate® Expert AI starts with the clinical evidence behind the answer.

It brings generative AI together with UpToDate’s expert-authored, peer-reviewed clinical content, where medical evidence is reviewed and interpreted by clinical experts. Healthcare professionals can ask questions in natural language and receive responses grounded in that content, with supporting sources they can examine.

The distinction is not simply about generating an answer. It is about making the evidence behind that answer visible and reviewable.

Clinical expertise also extends beyond the content itself. Clinical experts are involved in the development, evaluation and ongoing review of Expert AI.

That opens a wider question for hospitals considering AI:

Should healthcare AI be judged only by the quality of the answer it generates, or also by the evidence, transparency and human expertise behind it?

SPMC’s adoption provides a real-world setting in which to explore the questions public healthcare institutions may need to consider as AI becomes part of the wider healthcare technology landscape.

UpToDate Expert AI is considered a clinical decision support tool in the United States and certain other jurisdictions and a reference-only tool in others. Access may vary.

When anyone can ask AI about health, what should clinicians expect from theirs?

General-purpose generative AI has made health information readily accessible. In a professional healthcare setting, however, clinicians have additional considerations.

They need to understand where medical information comes from, what evidence supports it and whether the supporting sources can be examined.

The question for healthcare becomes: what should clinicians expect from AI designed specifically for their professional environment?

What makes clinical AI trustworthy?

Much of the debate around generative AI focuses on what the technology can do.

Healthcare introduces another question:

What is the answer actually based on?

UpToDate Expert AI offers a case study in a different approach: generative AI grounded in expert-authored, peer-reviewed clinical content, with supporting sources clinicians can review.

That creates a wider conversation around evidence provenance, transparency, clinical expertise and verifiability as healthcare organisations evaluate AI.

Who remains in control when AI enters healthcare?

AI adoption raises questions that extend beyond the technology itself.

How should clinicians evaluate its output? What role should governance play? How much transparency should clinicians expect? And where does professional judgement remain?

Expert AI is designed to support clinical reasoning, with transparent sourcing and continued professional judgement. The healthcare professional remains responsible for interpreting information in context and applying that judgement.

The technology therefore raises an interesting question about the future relationship between AI capability and human clinical expertise.

What can SPMC’s experience tell us?

As the first government hospital in the Southern Philippines to adopt UpToDate Expert AI, SPMC offers a local window into how public healthcare institutions are approaching emerging AI technologies.

Its experience can contribute to a wider discussion about what responsible AI adoption could look like in Philippine healthcare, including questions around evidence, transparency, governance, clinical oversight, and clinician adoption.

People to speak with

Dr. Sheila Bond, MD

Head of Clinical Artificial Intelligence, Wolters Kluwer Health

Dr. Sheila Bond leads Clinical AI Strategy for UpToDate and Provider Solutions, with a focus on responsible AI integration, transparency, governance and trust. She also holds a faculty appointment at Brigham and Women’s Hospital and Harvard Medical School.

Discussion points: What makes clinical AI trustworthy; why evidence provenance and transparency matter; how clinicians should evaluate AI-generated information; how clinical experts are involved in healthcare AI; responsible AI governance; and where professional judgement fits as AI capabilities advance.

Hong Nguyen

Regional Sales Director, APAC, Wolters Kluwer Health

Hong Nguyen can provide an Asia-Pacific perspective on healthcare innovation and the evolving adoption of clinical AI.

Discussion points: What APAC hospital leaders are asking about clinical AI; how approaches to adoption are evolving; and the role trust, evidence, and transparency may play in adoption.

Christian Cella, MBA

Vice President and General Manager, International, Wolters Kluwer Health

Christian Cella brings an international perspective on healthcare technology and digital transformation across health systems and ministries of health.

Discussion points: How health systems internationally are approaching AI; what responsible adoption looks like across different healthcare environments; and the role trusted clinical information could play as healthcare becomes increasingly digital.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information solutions, software and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2025 annual revenues of €6.1 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,100 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX, Euro Stoxx 50, and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information, visit www.wolterskluwer.com.